Eastman Chemical Co
EMNNYSECIK 915389MaterialsFiscal year ends Dec 31
Reports and events: 290 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-3011:18 ET | 10-Q | Quarterly reportPeriod 2026-09-30 | 0000915389-26-000172 |
| 2026-10-2916:19 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000915389-26-000167 |
| 2026-10-2016:10 ET | 8-K | 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0000915389-26-000161 |
| 2026-07-3111:10 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0000915389-26-000141 |
| 2026-07-3016:17 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000915389-26-000138 |
| 2026-05-1216:05 ET | 8-K | 5.07 Shareholder vote results | 0000915389-26-000123 |
| 2026-05-0111:58 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0000915389-26-000099 |
| 2026-04-3016:17 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000915389-26-000094 |
| 2026-03-2416:03 ET | DEF 14A | Proxy statementPeriod 2025-12-31 | 0000915389-26-000074 |
| 2026-02-2016:10 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-061351 |
| 2026-02-1311:58 ET | 10-K | Annual reportPeriod 2025-12-31 | 0000915389-26-000013 |
| 2026-01-2916:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000915389-26-000006 |
| 2025-11-0415:53 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0000915389-25-000183 |
| 2025-11-0316:19 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000915389-25-000176 |
| 2025-10-0916:13 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000915389-25-000160 |
| 2025-08-0110:52 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000915389-25-000155 |
| 2025-07-3116:19 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000915389-25-000152 |
| 2025-06-2708:51 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000915389-25-000136 |
| 2025-05-0609:25 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000915389-25-000129 |
| 2025-05-0517:08 ET | 8-K | 5.07 Shareholder vote results | 0000915389-25-000126 |
| 2025-04-2512:25 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000915389-25-000105 |
| 2025-04-2416:17 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000915389-25-000099 |
| 2025-03-2109:18 ET | DEF 14A | Proxy statementPeriod 2024-12-31 | 0000915389-25-000069 |
| 2025-03-1416:15 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-25-054808 |
| 2025-02-2116:15 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-032004 |
| 2025-02-1412:23 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000915389-25-000012 |
| 2025-01-3016:17 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000915389-25-000007 |
| 2024-11-2116:17 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-263415 |
| 2024-11-0111:24 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000915389-24-000227 |
| 2024-10-3116:17 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000915389-24-000225 |
| 2024-08-1216:36 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-198930 |
| 2024-08-0116:15 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-191526 |
| 2024-07-3018:17 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-187794 |
| 2024-07-2908:54 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-186764 |
| 2024-07-2611:02 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000915389-24-000192 |
| 2024-07-2516:28 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000915389-24-000189 |
| 2024-05-3116:06 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000915389-24-000172 |
| 2024-05-0716:37 ET | 8-K | 5.07 Shareholder vote results | 0001193125-24-133198 |
| 2024-04-2612:11 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000915389-24-000133 |
| 2024-04-2516:23 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000915389-24-000130 |
| 2024-03-2116:09 ET | DEF 14A | Proxy statementPeriod 2023-12-31 | 0000915389-24-000103 |
| 2024-02-2016:19 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-040003 |
| 2024-02-1416:21 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-24-036275 |
| 2024-02-1413:15 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000915389-24-000016 |
| 2024-02-0116:44 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000915389-24-000010 |
| 2023-12-1216:02 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-23-293362 |
| 2023-10-2710:56 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000915389-23-000170 |
| 2023-10-2616:19 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000915389-23-000166 |
| 2023-07-2812:24 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0000915389-23-000136 |
| 2023-07-2716:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000915389-23-000133 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 31, 2026, 12:26 ET. Listed shows no prices and gives no investment advice.